HIMS still going on FDA peptide headlines at highs +12.8% at $35.75
HIMS still going on FDA peptide headlines at highs +12.8% at $35.75
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.